Adriatic Liver Forum 2020 Preliminary program 

Thursday, 5th March 2020 

15:00-19:00 ULTRASOUND IN CHRONIC LIVER DISEASES

Hands-on course for young hepatologists (University hospital centre Split)


Friday, 6th March 2020

Cirrhosis and portal hypertension: from guidelines to individualized approach 

09:00-10:30  SESSION I: RECOGNIZING THE PROBLEM

Chairs: Ljubicic N, Ostojic R, Puljiz Z

Noninvasive tests for fibrosis and cirrhosis: are we ready for screening? / Gines P , ES

What about steatosis and NAFLD? / Mikolasevic I, HR

Noninvasive tests for portal hypertension / Grgurevic I, HR

How close we are to HCV elimination: data from Central Europe / Flisiak R, PL

11:00-12:30 SESSION II: PREVENTING THE COMPLICATIONS 

Chairs: Tonkic A, Trgo G

Primary prevention of variceal bleeding /Bosch J, ES

The role of gut microbioma in progression of cirrhosis and portal hypertension / Papp M, HU

Treatment of hepatitis C in patients with cirrhosis / Filipec-Kanizaj T, HR

Treatment of PBC / Jarcuska P, SK

Nutritional issues in cirrhosis / Krznaric Z, HR

12:30-13:30 LUNCH

13:30-15:00 SESSION III: PATIENT WITH ADVANCED CIRRHOSIS AND PORTAL HYPERTENSION I

Chairs: Milic S, Bosch J

Endoscopic treatment of acute variceal bleeding / Puljiz Z, HR

The role of TIPS / Patch D/Potts J, UK

Secondary prevention of variceal bleeding: guided or blinded? / Graupera I, ES

Renal injury in cirrhosis / Knezevic-Stromar I, HR

Severe alcoholic hepatitis / Virovic Jukic L, HR

15:30-17:00 SECTION IV: PATIENT WITH ADVANCED CIRRHOSIS AND PORTAL HYPERTENSION II

Chairs: Hrstic I, Ladic D

Frailty in cirrhosis / Skladany L, SK

Splanhnic thrombosis in cirrhosis: approach to treatment and monitoring / La Mura V, IT

Long-term outcome of patients with alcoholic liver cirrhosis / Stauber R, AT

Impact of outpatient care on survival in alcoholic cirrhosis / Tepes B, SI

20:00 Dinner for the participants


Saturday, 7th March 2020 

09:00-10:30 SECTION V: PERSONALIZED AND PRECISION MEDICINE IN CIRRHOSIS AND PH

Chairs: Bonacin D, LaMura V

Natural history and genetic determinants for progression of cirrhosis and portal hypertension / Tsochatzis E, UK

Artificial neural network prognostic modeling in cirrhosis / Salkic N, BH

Screening for HCC: current reccomendations / Milovanovic T, RS

New targets for the treatment of portal hypertension / Schwabl P, AT

10:30 CONCLUDING REMARKS